United Kingdom · Series A startup

Who invested in Verona Pharma

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2012, from 1 source

Latest round
Series A, $12MFeb 2012
Investors
1
See who backed them

The rounds

  1. Feb 2012
    Series A$12M
    • Henderson Global Investors

    Reported by onbiovc.com

Everyone who backed them

Henderson Global Investorsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Verona Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Vivo CapitalPrivate equityPer its own site
Aisling CapitalPrivate equityPer its own site
Andera PartnersPrivate equity2016, per its site

Quick answers about Verona Pharma

Who invested in Verona Pharma?

Verona Pharma's investors include Henderson Global Investors.

How much has Verona Pharma raised?

Verona Pharma has raised $12M across 1 round since 2012.

When did Verona Pharma last raise?

Verona Pharma's most recent round was a Series A of $12M in Feb 2012.

What was Verona Pharma's biggest round?

Its most recent round, $12M in Feb 2012, is also its largest on record.

Who backed Verona Pharma first?

Verona Pharma's first round on record, in Feb 2012, was backed by Henderson Global Investors.

What stage is Verona Pharma at?

Verona Pharma's latest named round is a Series A, in Feb 2012.

Where is Verona Pharma based?

Verona Pharma is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.